Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Melanoma recurrent: Which Medications Are Safest? (37 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

37 medications are used for Melanoma recurrent, with 186 combined adverse event reports. The most reported drugs for Melanoma recurrent are PEMBROLIZUMAB and NIVOLUMAB.

186
Total Reports
37
Drugs Used

All Medications for Melanoma recurrent Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
PEMBROLIZUMAB KEYTRUDA 66 15,543 35,472 18.6%
NIVOLUMAB OPDIVO 40 23,086 36,530 26.3%
IPILIMUMAB YERVOY 36 8,043 17,031 22.0%
TALIMOGENE LAHERPAREPVEC Imlygic 35 164 286 11.1%
DABRAFENIB Tafinlar 16 4,165 5,325 21.6%
METHYLPREDNISOLONE Medroloan II SUIK 9 12,828 26,552 20.1%
TRAMETINIB - 9 938 2,587 16.1%
TRAMETINIB DIMETHYL SULFOXIDE Mekinist 8 3,925 3,438 24.1%
INFLIXIMAB Renflexis 7 7,516 36,324 5.4%
RITUXIMAB Rituxan 7 28,910 54,631 16.2%
BINIMETINIB MEKTOVI 5 1,069 1,990 15.5%
ENCORAFENIB BRAFTOVI 5 1,397 2,334 16.3%
TEMOZOLOMIDE TEMOZOLOMIDE 5 3,099 4,302 18.2%

View all 37 drugs →

Most Reported Drugs for Melanoma recurrent

#1 most reported
#2 most reported
#3 most reported